Fig. 3
From: Predictable modulation of cancer treatment outcomes by the gut microbiota
Functional profiles of intestinal microbiota of cancer patients. a NMDS plot of cancer samples based on KEGG pathway abundances using Bray-Curtis dissimilarities (ANOSIM p = 0.0299). b Differentially abundant KEGG pathways (FDR p < 0.1, Wilcoxon rank-sum test) detected in the comparison of responders (R) and non-responders (NR). c CAZy class comparison between R and NR. *p < 0.1, **p < 0.05. d Performance of the C5.0 decision tree models in classifying R and NR